Omega Healthcare Investors Appoints New CEO, Matthew P. Gourmand

What Happened

• Omega Healthcare Investors, Inc. (OHI) filed an 8-K under Item 5.02 reporting that, effective October 1, 2026, the Board appointed Matthew P. Gourmand — who has been the Company’s President since January 1, 2025 — to succeed C. Taylor Pickett as Chief Executive Officer. The Board also appointed Mr. Gourmand as a director to fill Mr. Pickett’s board vacancy for the remainder of the term expiring in 2027. Mr. Pickett’s retirement was not due to any disagreement with the Company.

Key Details

• Effective date: October 1, 2026.
• Board composition: total directors remains eight; Gourmand fills Pickett’s board seat through 2027.
• Background: Gourmand (age 51) was President since Jan 1, 2025; SVP of Corporate Strategy & Investor Relations (since Jan 2021); prior roles include equity portfolio manager and analyst positions and audit experience at Deloitte. He holds an LLB (University College London) and the CFA designation.
• Governance/compensation: Board does not expect to place him on any committees at filing time; no separate director compensation will be paid beyond his employment agreement; no related-party transactions or family relationships reported.

Why It Matters

• This is an internal leadership succession that provides continuity at the CEO level by promoting the sitting President who already leads company strategy and investor relations. For investors, the change signals a planned transition (not a disagreement) and keeps the board size and oversight unchanged. The filing does not disclose changes to compensation beyond existing employment terms.